complaint·December 13, 2022

On 12/13/22, Licensing Program Analyst (LPA) Tung Truong conducted an unannounced visit to this facility to deliver the complaint findings. LPA met with Administrator Guadalupe Ramirez and explained the purpose of today’s visit. Throughout the course of the investigation, LPA conducted interviews and reviewed records. Based on the investigation, it was learned that resident (R1) is on hospice. It was observed that the facility was following Bristol Hospice's orders to provide R1 Norco 1 tablets orally 3 times a day for pain and morphine as needed. As a result of this investigation, LPA finds the allegation above to be UNFOUNDED, meaning that the allegation was false, could not have happened and/or was without a reasonable basis. Exit interview was conducted with Administrator Guadalupe Ramirez and a copy of the report was provided.